| UHC Commercial Medical & Drug | Respiratory Interleukins (Cinqair®, Fasenra®, & Nucala®) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Respiratory Pathogen Nucleic Acid Detection Testing – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Rhinoplasty and Other Nasal Procedures – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Spinal Fusion and Decompression – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Uplizna® (Inebilizumab-Cdon) – Commercial Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Upper Extremity Prosthetic Devices – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Vertebral Body Tethering for Scoliosis – Commercial and Individual Exchange Medical Policy | 2026-04-01 |
| Humana Medicare Advantage | Computer Assisted Surgical Navigation for Musculoskeletal Procedures - Medicare Advantage | 2026-04-01 |
| Humana Medicare Advantage | Hyperthermia and Ultrasound-Based Ablative Cancer Treatments - Medicare Advantage | 2026-04-01 |
| BCBS Premera WA AK Clinical | Surgical Treatment of Snoring and Obstructive Sleep | 2026-04-01 |